A pharmaceutical research centre in Abuja, Ben Amodu Firms and Research
Center, Saturday said it has submitted drug samples to the Federal
Government that have the efficacy to tackle Ebola virus.
The
Chairman of the Centre, Pharmacist Ben Amodu, said the centre had
produced drugs for the treatment of haemorrhagic fevers, which could
also be used for Ebola virus.
He said the drugs have been submitted to the committee set up by the minister of health recently on Ebola adding that
“We
gave the National Agency for Food and Drug Administration and Control
(NAFDAC) and World Health Organization (WHO) samples of the drugs but
the WHO later phoned and said they were not supposed to verify Ebola
drugs. I gave samples to the committee set by the Minister of Health on
Ebola virus and I hope that due process will be followed in
He said the Centre was into research of neglected tropical diseases, adding that the drugs
He
said, “We got the drugs that cure Leishmaniasis and they have been
previewed. We invented a drug, DAABS 2 which also cures Dangue fever
which is viral Hemorrhagic fever and as you know Ebola is also a viral
Hemorrhagic fever. Their symptoms include fever, intense weakness of the
body system, vomiting, diarrhea, headache and internal and external
bleeding. If you remove the bleeding aspect the disease becomes typhoid
and
"The International Organisation for Scientific Research based
in US, Japan and India have also previewed us for the management of
hepatitis A,B,C,D,E and F, of which we have treated so many people. We
have a drug that stops bleeding, including those from cervical cancer
and uncontrolled menstrual flow. Our drug called SAABMAL was tested by
the World Health Organization to have 97 per cent effectiveness in all
forms of fever symptoms, including
"Another drug, TAABS 2 also
has effects on fever while SAAB 6 has very strong Antioxidant and
anti-inflammatory properties as confirmed by National Institute for
Pharmaceutical Research and Development (NIPRD). Also one other drug
SAAB is a very good immune booster"
No comments:
Post a Comment